Erawan Borkham-Kamphorst

Inhibitory effect of soluble PDGF-beta receptor in culture-activated hepatic stellate cells.

Dominant-negative soluble PDGF-beta receptor inhibits hepatic stellate cell activation and attenuates liver fibrosis.

Antisense strategy against PDGF B-chain proves effective in preventing experimental liver fibrogenesis.

Cryopreservation of hepatic stellate cells.

Disruption of intermolecular disulfide bonds in PDGF-BB dimers by N-acetyl-L-cysteine does not prevent PDGF signaling in cultured hepatic stellate cells.

The expression of CSRP2 encoding the LIM domain protein CRP2 is mediated by TGF-beta in smooth muscle and hepatic stellate cells.

Pro-fibrogenic potential of PDGF-D in liver fibrosis.

Platelet-derived growth factor isoform expression in carbon tetrachloride-induced chronic liver injury.

BMP-7 as antagonist of organ fibrosis.

Expression and functional analysis of endoglin in isolated liver cells and its involvement in fibrogenic Smad signalling.

Induction of lipocalin-2 expression in acute and chronic experimental liver injury moderated by pro-inflammatory cytokines interleukin-1β through nuclear factor-κB activation.

CCN3/NOV small interfering RNA enhances fibrogenic gene expression in primary hepatic stellate cells and cirrhotic fat storing cell line CFSC.

Chemokine Cxcl9 attenuates liver fibrosis-associated angiogenesis in mice.

A novel, dual role of CCN3 in experimental glomerulonephritis: pro-angiogenic and antimesangioproliferative effects.

Adenoviral CCN3/NOV gene transfer fails to mitigate liver fibrosis in an experimental bile duct ligation model because of hepatocyte apoptosis.

Factor VII activating protease (FSAP) exerts anti-inflammatory and anti-fibrotic effects in liver fibrosis in mice and men.

Proapoptotic effects of the chemokine, CXCL 10 are mediated by the noncognate receptor TLR4 in hepatocytes.

Platelet-Derived Growth Factor (PDGF)-C Neutralization Reveals Differential Roles of PDGF Receptors in Liver and Kidney Fibrosis.

Expression analysis of inflammasomes in experimental models of inflammatory and fibrotic liver disease.

Proteomic profiling in Lipocalin 2 deficient mice under normal and inflammatory conditions.

Protective effects of lipocalin-2 (LCN2) in acute liver injury suggest a novel function in liver homeostasis.

The anti-fibrotic effects of CCN1/CYR61 in primary portal myofibroblasts are mediated through induction of reactive oxygen species resulting in cellular senescence, apoptosis and attenuated TGF-β signaling.

Human mesenchymal stem cells towards non-alcoholic steatohepatitis in an immunodeficient mouse model.

Lipocalin-2 (LCN2) regulates PLIN5 expression and intracellular lipid droplet formation in the liver.

Platelet-derived growth factor-D modulates extracellular matrix homeostasis and remodeling through TIMP-1 induction and attenuation of MMP-2 and MMP-9 gelatinase activities.